Objective Treatment compliance among psychiatric patients is related to disease outcomes. How to assess patient compliance remains a concern. Here, we established a predictive model for medication ...

The following is a summary of “Engagement in a virtual group-based walking intervention for persons with schizophrenia: a qualitative study,” published in the November 2024 issue of Psychiatry by ...

For patients with schizophrenia, repetitive transcranial magnetic stimulation (rTMS) was effective and safe in treating ...

Dr. Tom Keenan is an award-winning journalist, public speaker, professor in the School of Architecture, Planning and ...

Researchers have developed a potential diagnostic tool for schizophrenia by observing how patients process conflicting information.

"Our goal was to derive a biomarker for executive dysfunction in schizophrenia, which only emerged when patients were taxed ...

Recently approved xanomeline and trospium chloride (Cobenfy) demonstrated long-term efficacy and safety in patients with ...

Some people who took a new schizophrenia drug for a year improved ... homelessness and unemployment. So why did some patients stick with treatment while others dropped out? Krystal said it will ...

Some people who took a new schizophrenia drug for one year improved with only a few side effects, but many dropped out of the research. That’s according to company-sponsored studies reported ...

This study explored the agreement or discrepancy between subjective difficulties in social cognition and actual cognitive ...

(Radio-Canada) A disease that is more commonly associated with the trenches of the First World War, and can sometimes be found in refugee camps, has been detected in several patients in Alberta ...